These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 28713867)

  • 1. Circadian Dysregulation in Parkinson's Disease.
    Videnovic A; Golombek D
    Neurobiol Sleep Circadian Rhythms; 2017 Jan; 2():53-58. PubMed ID: 28713867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Progress in Non-motor Features of Parkinson's Disease with a Focus on Circadian Rhythm Dysregulation.
    Liu Y; Niu L; Liu X; Cheng C; Le W
    Neurosci Bull; 2021 Jul; 37(7):1010-1024. PubMed ID: 34128188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronobiology of Parkinson's disease: Past, present and future.
    Asadpoordezaki Z; Coogan AN; Henley BM
    Eur J Neurosci; 2023 Jan; 57(1):178-200. PubMed ID: 36342744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circadian clock disruption promotes the degeneration of dopaminergic neurons in male Drosophila.
    Majcin Dorcikova M; Duret LC; Pottié E; Nagoshi E
    Nat Commun; 2023 Sep; 14(1):5908. PubMed ID: 37737209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disturbances of Sleep and Alertness in Parkinson's Disease.
    Videnovic A
    Curr Neurol Neurosci Rep; 2018 Apr; 18(6):29. PubMed ID: 29675716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A disruption mechanism of the molecular clock in a MPTP mouse model of Parkinson's disease.
    Hayashi A; Matsunaga N; Okazaki H; Kakimoto K; Kimura Y; Azuma H; Ikeda E; Shiba T; Yamato M; Yamada K; Koyanagi S; Ohdo S
    Neuromolecular Med; 2013 Jun; 15(2):238-51. PubMed ID: 23292542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease.
    Hennis MR; Marvin MA; Taylor CM; Goldberg MS
    Neurobiol Dis; 2014 Feb; 62():113-23. PubMed ID: 24075852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease as a neuroendocrine disorder of circadian function: dopamine-melatonin imbalance and the visual system in the genesis and progression of the degenerative process.
    Willis GL
    Rev Neurosci; 2008; 19(4-5):245-316. PubMed ID: 19145986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian and sleep disorders in Parkinson's disease.
    Videnovic A; Golombek D
    Exp Neurol; 2013 May; 243():45-56. PubMed ID: 22935723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
    Korecka JA; Moloney EB; Eggers R; Hobo B; Scheffer S; Ras-Verloop N; Pasterkamp RJ; Swaab DF; Smit AB; van Kesteren RE; Bossers K; Verhaagen J
    J Neurosci; 2017 Sep; 37(39):9361-9379. PubMed ID: 28842419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic Neurons Exhibit an Age-Dependent Decline in Electrophysiological Parameters in the MitoPark Mouse Model of Parkinson's Disease.
    Branch SY; Chen C; Sharma R; Lechleiter JD; Li S; Beckstead MJ
    J Neurosci; 2016 Apr; 36(14):4026-37. PubMed ID: 27053209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian rhythms, Neuroinflammation and Oxidative Stress in the Story of Parkinson's Disease.
    Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
    Cells; 2020 Jan; 9(2):. PubMed ID: 32012898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian Rhythm Abnormalities in Parkinson's Disease from Humans to Flies and Back.
    De Lazzari F; Bisaglia M; Zordan MA; Sandrelli F
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian system - A novel diagnostic and therapeutic target in Parkinson's disease?
    Videnovic A; Willis GL
    Mov Disord; 2016 Mar; 31(3):260-9. PubMed ID: 26826022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abrogation of the Circadian Nuclear Receptor REV-ERBα Exacerbates 6-Hydroxydopamine-Induced Dopaminergic Neurodegeneration.
    Kim J; Jang S; Choi M; Chung S; Choe Y; Choe HK; Son GH; Rhee K; Kim K
    Mol Cells; 2018 Aug; 41(8):742-752. PubMed ID: 30078232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orexin pathway in Parkinson's disease: a review.
    Alrouji M; Al-Kuraishy HM; Al-Gareeb AI; Zaafar D; Batiha GE
    Mol Biol Rep; 2023 Jul; 50(7):6107-6120. PubMed ID: 37155018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of Circadian Rhythm in Dopamine and Mood Regulation.
    Kim J; Jang S; Choe HK; Chung S; Son GH; Kim K
    Mol Cells; 2017 Jul; 40(7):450-456. PubMed ID: 28780783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of gene mutation in the development of Parkinson's disease.
    Selvaraj S; Piramanayagam S
    Genes Dis; 2019 Jun; 6(2):120-128. PubMed ID: 31193965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome.
    Kou L; Chi X; Sun Y; Han C; Wan F; Hu J; Yin S; Wu J; Li Y; Zhou Q; Zou W; Xiong N; Huang J; Xia Y; Wang T
    J Neuroinflammation; 2022 Jun; 19(1):133. PubMed ID: 35668454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's Disease is Associated with Dysregulations of a Dopamine-Modulated Gene Network Relevant to Sleep and Affective Neurobehaviors in the Striatum.
    Jiang P; Scarpa JR; Gao VD; Vitaterna MH; Kasarskis A; Turek FW
    Sci Rep; 2019 Mar; 9(1):4808. PubMed ID: 30886221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.